The study aims to assess the effects of daily consumption of nutrients-fortified eggs on eczema condition in individuals with eczema. It is hypothesised that daily consumption of nutrients-fortified egg, which is rich in antioxidants, will improve eczema conditions in individuals with eczema as compared to consumption of regular eggs.
Age range
21 Years – 59 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in eczema severity using the SCORing Atopic Dermatitis (SCORAD) index
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in eczema severity using the Eczema Area Severity Index (EASI)
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in skin quality of life assessment using the Dermatology Life Quality Index (DLQI)
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in skin hydration level using corneometer
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in transepidermal water loss level using tewameter
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in skin pH level using pH probe
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in skin sebum level using sebumeter
Timeframe: Every 3 weeks (Week 0, Week 3, Week 6, Week 9, Week 12)
Change in stratum corneum components via immune dot blot assay
Timeframe: Baseline and Week 12
Change in malondialdehyde level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in 8-iso-prostaglandin F2α level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in interleukin-6 level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in tumor necrosis factor α
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in fasting blood glucose level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in blood triglyceride level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in blood total cholesterol level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in blood Low-density Lipoprotein-cholesterol (LDL) level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)
Change in blood High-density Lipoprotein-cholesterol (HDL) level
Timeframe: Every 6 weeks (Week 0, Week 6, Week 12)